These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20825317)

  • 21. NIAID describes research priorities for fighting drug-resistant tuberculosis.
    Home Healthc Nurse; 2008 Sep; 26(8):448-9. PubMed ID: 18787482
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence-based prevention of MDR-TB: an intervention whose time has come.
    Horsburgh CR
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):259. PubMed ID: 20132611
    [No Abstract]   [Full Text] [Related]  

  • 23. Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis.
    Dye C; Williams BG; Espinal MA; Raviglione MC
    Science; 2002 Mar; 295(5562):2042-6. PubMed ID: 11896268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tuberculosis as an international and national problem].
    Khomenko AG
    Probl Tuberk; 1994; (2):2-4. PubMed ID: 8036208
    [No Abstract]   [Full Text] [Related]  

  • 25. Tuberculosis recommendations.
    Coker RJ
    Sex Transm Infect; 1998 Aug; 74(4):240-2. PubMed ID: 9924460
    [No Abstract]   [Full Text] [Related]  

  • 26. Break through multidrug-resistant TB.
    Gribble EA; Williams A
    Nurse Pract; 2010 Mar; 35(3):14-22; quiz 22-3. PubMed ID: 20164730
    [No Abstract]   [Full Text] [Related]  

  • 27. Multidrug-resistant tuberculosis: a new era in prevention and control.
    Serkey JM
    Dimens Crit Care Nurs; 1995; 14(5):236-44. PubMed ID: 7656766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].
    Santos-Preciado JI; Franco-Paredes C
    Rev Invest Clin; 2005; 57(3):488-90. PubMed ID: 16187710
    [No Abstract]   [Full Text] [Related]  

  • 29. Extensively drug-resistant tuberculosis. Recent outbreaks highlight the need for improved prevention, control, and surveillance programs.
    Todd B
    Am J Nurs; 2007 Jun; 107(6):29-31. PubMed ID: 17519597
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug resistant tuberculosis: a global public health issue.
    Sampathkumar P
    Int J Dermatol; 2008 Oct; 47(10):985-8. PubMed ID: 18986340
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug resistant tuberculosis.
    Kamholz SL
    J Assoc Acad Minor Phys; 2002 Apr; 13(2):53-6. PubMed ID: 12362568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.
    Paramasivan CN; Rehman F; Wares F; Sundar Mohan N; Sundar S; Devi S; Narayanan PR
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):243-6. PubMed ID: 20074419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi drug resistant tuberculosis.
    Dey AB; Nagarkar K
    Trop Gastroenterol; 1995; 16(2):92-100. PubMed ID: 8644369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. World tuberculosis control: how far have we to go?
    Enarson DA
    Int J Tuberc Lung Dis; 2000 Dec; 4(12 Suppl 2):S219-23. PubMed ID: 11144556
    [No Abstract]   [Full Text] [Related]  

  • 35. DOTS and drug resistance: a silver lining to a darkening cloud.
    Chaisson RE; Coberly JS; De Cock KM
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):1-3. PubMed ID: 10094162
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug-resistant tuberculosis: past, present, future.
    Chiang CY; Centis R; Migliori GB
    Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global incidence of multidrug-resistant tuberculosis.
    Zignol M; Hosseini MS; Wright A; Weezenbeek CL; Nunn P; Watt CJ; Williams BG; Dye C
    J Infect Dis; 2006 Aug; 194(4):479-85. PubMed ID: 16845631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug-resistant tuberculosis.
    Wkly Epidemiol Rec; 2001 Sep; 76(36):273. PubMed ID: 11573306
    [No Abstract]   [Full Text] [Related]  

  • 39. Rational 'DOTS plus' for the control of MDR-TB.
    Espinal MA; Dye C; Raviglione M; Kochi A
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):561-3. PubMed ID: 10423218
    [No Abstract]   [Full Text] [Related]  

  • 40. New tools for achieving tuberculosis control: progress and reflexion.
    Zumla A; Yew WW
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):285-6. PubMed ID: 21333093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.